Authors


Donghui Jing, PhD

Latest:

Growth Kinetics of Human Mesenchymal Stem Cells in a 3-L Single-Use, Stirred-Tank Bioreactor

The authors describe the growth characteristics of human mesenchymal stem cells cultured in a stirred-tank bioreactor.


David Horn

Latest:

Identification and Quantification of Trace-Level Protein Impurities

A simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics is described.


Gerry McAuley

Latest:

Optimizing Human Performance: A Road Worth Traveling, Part 3

This article is the third and final in a series designed to offer leaders and managers at all levels in the industry a road map to excellence in human performance and human error prevention.


Andrew Nason

Latest:

Patents and Postapproval Batch Testing

Can postapproval FDA filings immunize pharma companies from patent lawsuits?



Chris Masterson

Latest:

Managing Contract Manufacturing Organization Relationships

Successful management of the CMO/client relationship should include open communication and trust.


Gillian R. Woollett

Latest:

Biologics: Can There Be Abbreviated Applications, Generics, or Follow-On Products?

In this question-and-answer discussion of "generic" biologics, the authors contend small changes in manufacturing of biologics dramatically affect the safety and efficacy of the therapeutic molecule.


Parrish Galliher

Latest:

When the Process Becomes the Product: Single-Use Technology and the Next Biomanufacturing Paradigm

The move to single-use manufacturing has prompted a paradigm shift in facility design.



Patrick Bennett

Latest:

Identification and Quantification of Trace-Level Protein Impurities

A simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics is described.


Clinton Weber

Latest:

Quality by Design: A CMO's Perspective on Gaining Knowledge Faster and Better

Traditional project decision-making vs. a QbD approach.


Jens H. Vogel, PhD

Latest:

Polishing Complex Therapeutic Proteins

A new downstream purification platform using a salt-tolerant membrane adsorber.


Tom Fletcher

Latest:

Safety Drives Innovation in Animal-Component-Free Cell-Culture Media Technology

Advances in cell culture media technology have helped achieve safer biologics.


Ronald A. Rader

Latest:

Cellular and Gene Therapies Face a Manufacturing Capacity Crunch

Cellular and gene therapy fields are currently on track for, if not already experiencing, a serious capacity crunch.


George Oulundsen

Latest:

Single-Use Redundant Filtration

The authors describe a new assembly for bulk and final drug product filling operations.




Peter Latham

Latest:

Costing Issues in the Production of Biopharmaceuticals

Operational planning and early cost analyses are key to generating optimal, robust, and economical commercial processes.


Ron Lee

Latest:

Ice Fog as a Means to Induce Uniform Ice Nucleation During Lyophilization (Peer Reviewed)

The authors describe a novel means to control ice nucleation using a sterile cryogenic ice fog.


Lars Gøran Wistrand

Latest:

A Method for Removal of Endotoxin from Pharmaceutical Formulation

The authors describe a simple method to remove endotoxins from highly viscous formulations.


Ernest Jenness

Latest:

Single-Use Technology for Syringe Filling

A novel approach to sterile drug product manufacturing uses a single-use assembly in a multi-product final filling suite with isolator technology.



Christopher Milne

Latest:

The Case for Pediatric Exclusivity

Reauthorization of pediatric exclusivity provisions looms in 2012 and debates begin anew.



Robert B. Burlingame

Latest:

A Protocol for Trademark Protection

The Madrid Protocol offers companies another option for trademark registration on a global scale.


Vijesh Kumar

Latest:

Mechanistic Modeling of Preparative Ion-Exchange Chromatography

Chromatography modeling can enhance bioprocessing efficiencies.




Paul Nelles

Latest:

Strategic Outsourcing in Clinical Development

Partnering with CDMOs can help bridge the innovation gap.


Arie Geursen

Latest:

HIV Drugs Produced from Goats Show Promise

Molecular mimicry is a common, but undesirable, property of disease proteins. Sequence similarities between cancer proteins and self-proteins allow tumor cells to hide, thereby avoiding attack from the immune system. HIV uses the same evasive tactic.

© 2025 MJH Life Sciences

All rights reserved.